Chemed Corporation $CHE Shares Sold by Legal & General Group Plc

Legal & General Group Plc decreased its stake in Chemed Corporation (NYSE:CHE) by 19.6% in the 4th quarter, HoldingsChannel reports. The institutional investor owned 23,457 shares of the company’s stock after selling 5,734 shares during the period. Legal & General Group Plc’s holdings in Chemed were worth $10,036,000 as of its most recent SEC filing.

Several other large investors have also modified their holdings of CHE. Northwestern Mutual Wealth Management Co. lifted its position in shares of Chemed by 2,444,879.3% during the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 5,550,103 shares of the company’s stock worth $2,374,667,000 after purchasing an additional 5,549,876 shares in the last quarter. JPMorgan Chase & Co. increased its stake in Chemed by 122.7% during the third quarter. JPMorgan Chase & Co. now owns 499,968 shares of the company’s stock valued at $223,856,000 after purchasing an additional 275,423 shares during the last quarter. AQR Capital Management LLC increased its stake in Chemed by 160.9% during the second quarter. AQR Capital Management LLC now owns 201,041 shares of the company’s stock valued at $97,893,000 after purchasing an additional 123,982 shares during the last quarter. M&T Bank Corp increased its stake in Chemed by 10,291.1% during the fourth quarter. M&T Bank Corp now owns 85,934 shares of the company’s stock valued at $36,768,000 after purchasing an additional 85,107 shares during the last quarter. Finally, Arrowstreet Capital Limited Partnership increased its stake in Chemed by 740.9% during the third quarter. Arrowstreet Capital Limited Partnership now owns 95,573 shares of the company’s stock valued at $42,792,000 after purchasing an additional 84,208 shares during the last quarter. Institutional investors and hedge funds own 95.85% of the company’s stock.

Insider Activity

In other news, CEO Kevin J. Mcnamara sold 2,000 shares of the stock in a transaction that occurred on Friday, May 1st. The shares were sold at an average price of $421.13, for a total value of $842,260.00. Following the completion of the sale, the chief executive officer directly owned 90,219 shares of the company’s stock, valued at $37,993,927.47. This represents a 2.17% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. 3.33% of the stock is owned by company insiders.

Wall Street Analyst Weigh In

Several brokerages have recently issued reports on CHE. Oppenheimer reduced their price target on shares of Chemed from $580.00 to $500.00 and set an “outperform” rating for the company in a report on Friday, February 27th. Royal Bank Of Canada boosted their price target on shares of Chemed from $422.00 to $436.00 and gave the stock a “sector perform” rating in a research report on Monday, April 27th. Weiss Ratings upgraded shares of Chemed from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Wednesday, April 29th. Zacks Research upgraded shares of Chemed from a “strong sell” rating to a “hold” rating in a research report on Monday, April 27th. Finally, Wall Street Zen upgraded shares of Chemed from a “hold” rating to a “buy” rating in a research report on Sunday, May 31st. Two equities research analysts have rated the stock with a Buy rating and four have given a Hold rating to the stock. According to MarketBeat, Chemed presently has an average rating of “Hold” and an average target price of $501.50.

Chemed Stock Performance

Shares of CHE opened at $431.70 on Friday. Chemed Corporation has a one year low of $365.20 and a one year high of $565.66. The company has a 50-day moving average of $408.07 and a two-hundred day moving average of $424.45. The stock has a market cap of $5.73 billion, a price-to-earnings ratio of 23.53, a PEG ratio of 1.60 and a beta of 0.54. The company has a debt-to-equity ratio of 0.11, a current ratio of 0.85 and a quick ratio of 0.83.

Chemed (NYSE:CHE) last announced its earnings results on Thursday, April 23rd. The company reported $5.65 EPS for the quarter, topping the consensus estimate of $5.30 by $0.35. The company had revenue of $657.51 million during the quarter, compared to analysts’ expectations of $659.22 million. Chemed had a net margin of 10.23% and a return on equity of 27.18%. The business’s revenue for the quarter was up 1.6% on a year-over-year basis. During the same period last year, the company posted $5.63 earnings per share. Chemed has set its FY 2026 guidance at 24.000-24.75 EPS. On average, equities research analysts expect that Chemed Corporation will post 22.3 earnings per share for the current year.

Chemed Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Tuesday, June 16th. Stockholders of record on Thursday, May 28th will be given a $0.60 dividend. This represents a $2.40 dividend on an annualized basis and a dividend yield of 0.6%. The ex-dividend date of this dividend is Thursday, May 28th. Chemed’s dividend payout ratio is 13.08%.

About Chemed

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.